ロード中...
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Synthetic gabapentinoids, exemplified by gapapentin and pregabalin, are in extensive clinical use for indications including epilepsy, neuropathic pain, anxiety, and alcohol withdrawal. Their mechanisms of action are incompletely understood, but are thought to involve inhibition of α(2)δ subunit–cont...
保存先:
| 出版年: | Mol Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108572/ https://ncbi.nlm.nih.gov/pubmed/30021858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.118.112953 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|